A medical device implanted in the patient’s head
The implanted medical device uses near-infrared light to stimulate neuronal activity and potentially slow the progression of the disease. This approach, known as photobiomodulation, aims to offer a new therapeutic option for patients who do not respond well to traditional drug treatments. This innovative technique represents a significant advance in the treatment of Parkinson’s disease, offering hope to patients. Patrons of the Fonds Clinatec have supported this project from the outset, in particular to establish preclinical proof of neuroprotection by light.
The article also mentions pathologies for which transcranial photobiomodulation (i.e. photomodulation that passes through the skull, from the outside) could be a solution, and on which the Fonds Clinatec has launched new research projects: Alzheimer’s disease, sleep disorders and cranial trauma. The NIR project is led by Professor Stéphan Chabardès and Cécile Moro, based on an original idea by Professor Alim-Louis Benabid.
